Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Current and future treatments for peanut allergy
Tricia Lee
, Sofia Edwards-Salmon
, Brian P. Vickery
Research output
:
Contribution to journal
›
Review article
›
peer-review
8
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Current and future treatments for peanut allergy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Peanut Allergy
100%
Peanut Oral Immunotherapy
100%
Therapeutic Intervention
33%
New Therapeutics
33%
Shared Decision Making
33%
Treatment Goals
33%
Monotherapy
33%
New Therapies
33%
Adulthood
33%
Childhood Diseases
33%
Adjunctive Therapy
33%
Future Therapeutics
33%
Peanut
33%
FDA-approved Drugs
33%
Risk-benefit
33%
Sublingual
33%
Allergy Practice
33%
Omalizumab
33%
Preschoolers
33%
Patient Goals
33%
Epicutaneous
33%
Allergist
33%
Therapeutic Landscapes
33%
Palforzia
33%
Intralymphatic
33%
Medicine and Dentistry
Peanut Allergy
100%
Oral Immunotherapy
100%
Biological Product
66%
Monotherapy
33%
Immunotherapy
33%
Childhood Disease
33%
Shared Decision Making
33%
Omalizumab
33%
Pharmacology, Toxicology and Pharmaceutical Science
Immunotherapy
100%
Peanut Allergy
100%
Peanut
100%
Biological Product
50%
Monotherapy
25%
Childhood Disease
25%
Omalizumab
25%
Immunology and Microbiology
Immunotherapy
100%
Peanut Allergy
100%
Biological Product
50%
Omalizumab
25%
Shared Decision Making
25%
Neuroscience
Immunotherapy
100%
Decision-Making
25%
Omalizumab
25%